Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
20 07 2022
Historique:
received: 16 04 2021
accepted: 07 07 2021
pubmed: 15 7 2021
medline: 26 7 2022
entrez: 14 7 2021
Statut: ppublish

Résumé

Optimal risk stratification with machine learning (ML) from myocardial perfusion imaging (MPI) includes both clinical and imaging data. While most imaging variables can be derived automatically, clinical variables require manual collection, which is time-consuming and prone to error. We determined the fewest manually input and imaging variables required to maintain the prognostic accuracy for major adverse cardiac events (MACE) in patients undergoing a single-photon emission computed tomography (SPECT) MPI. This study included 20 414 patients from the multicentre REFINE SPECT registry and 2984 from the University of Calgary for training and external testing of the ML models, respectively. ML models were trained using all variables (ML-All) and all image-derived variables (including age and sex, ML-Image). Next, ML models were sequentially trained by incrementally adding manually input and imaging variables to baseline ML models based on their importance ranking. The fewest variables were determined as the ML models (ML-Reduced, ML-Minimum, and ML-Image-Reduced) that achieved comparable prognostic performance to ML-All and ML-Image. Prognostic accuracy of the ML models was compared with visual diagnosis, stress total perfusion deficit (TPD), and traditional multivariable models using area under the receiver-operating characteristic curve (AUC). ML-Minimum (AUC 0.798) obtained comparable prognostic accuracy to ML-All (AUC 0.799, P = 0.19) by including 12 of 40 manually input variables and 11 of 58 imaging variables. ML-Reduced achieved comparable accuracy (AUC 0.796) with a reduced set of manually input variables and all imaging variables. In external validation, the ML models also obtained comparable or higher prognostic accuracy than traditional multivariable models. Reduced ML models, including a minimum set of manually collected or imaging variables, achieved slightly lower accuracy compared to a full ML model but outperformed standard interpretation methods and risk models. ML models with fewer collected variables may be more practical for clinical implementation.

Identifiants

pubmed: 34259870
pii: 6321228
doi: 10.1093/cvr/cvab236
pmc: PMC9302886
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2152-2164

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Références

J Nucl Cardiol. 2020 Jun;27(3):1010-1021
pubmed: 29923104
Biometrics. 2005 Mar;61(1):92-105
pubmed: 15737082
Circulation. 2007 Nov 27;116(22):2634-53
pubmed: 17951284
Eur Heart J Cardiovasc Imaging. 2021 May 10;22(6):705-714
pubmed: 32533137
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
J Am Coll Cardiol. 2019 Mar 26;73(11):1317-1335
pubmed: 30898208
J Am Coll Cardiol. 2012 Dec 18;60(24):e44-e164
pubmed: 23182125
PLoS One. 2008 Aug 25;3(8):e3049
pubmed: 18725958
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
BMJ Open. 2013 May 28;3(5):
pubmed: 23793682
Eur Heart J. 2017 Feb 14;38(7):500-507
pubmed: 27252451
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
J Nucl Cardiol. 2019 Oct;26(5):1746-1754
pubmed: 29542015
JACC Cardiovasc Imaging. 2018 Jul;11(7):1000-1009
pubmed: 29055639
JMIR Med Inform. 2019 Aug 30;7(3):e13139
pubmed: 31471957
Eur Heart J Cardiovasc Imaging. 2020 May 1;21(5):549-559
pubmed: 31317178

Auteurs

Richard Rios (R)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Robert J H Miller (RJH)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada.

Lien Hsin Hu (LH)

Department of Nuclear Medicine, Taipei, Veterans General Hospital, Taipei, Taiwan.

Yuka Otaki (Y)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Ananya Singh (A)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Marcio Diniz (M)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Tali Sharir (T)

Department of Nuclear Cardiology, Assuta Medical Center, Tel Aviv, Israel.
Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel.

Andrew J Einstein (AJ)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA.
Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA.

Mathews B Fish (MB)

Department of Nuclear Medicine, Oregon Heart and Vascular Institute, Sacred Heart Medical Center, Springfield, OR, USA.

Terrence D Ruddy (TD)

Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa ON, Canada.

Philipp A Kaufmann (PA)

Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.

Albert J Sinusas (AJ)

Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.

Edward J Miller (EJ)

Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.

Timothy M Bateman (TM)

Cardiovascular Imaging Technologies LLC, Kansas City, MO, USA.

Sharmila Dorbala (S)

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.

Marcelo DiCarli (M)

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.

Serge Van Kriekinge (S)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Paul Kavanagh (P)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Tejas Parekh (T)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Joanna X Liang (JX)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Damini Dey (D)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Daniel S Berman (DS)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Piotr Slomka (P)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH